G20

G20 Therapeutics is a biotechnology company focused on the discovery and development of novel therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes a specialized platform to identify and modulate high-value GPCR targets involved in metabolic and endocrine diseases. With a primary focus on conditions like obesity and type 2 diabetes, G20 Therapeutics leverages deep expertise in structural biology and pharmacology to create next-generation small molecule and peptide treatments. The company is led by prominent researchers in the GPCR field and operates with a mission to address significant unmet needs in metabolic health.